UPDATE 1-Canada’s IMRIS files for US IPO

* Underwriters include Canaccord Genuity, Lazard Capital

* Says applied for Nasdaq listing

Nov 8 (BestGrowthStock) – Canada’s IMRIS Inc (IM.TO: ), which makes
magnetic resonance imaging systems, on Monday filed with
regulators for an initial public offering of its common stock
in the United States.

IMRIS, currently listed on the Toronto Stock Exchange, said
it plans to offer 10 million shares in the offering, while
selling shareholders will offer 3.7 million shares. The filing
did not reveal their expected price.

The company told the U.S. Securities and Exchange
Commission in a preliminary prospectus that Canaccord Genuity,
Lazard Capital Markets, Wedbush PacGrow Life Sciences, GMP
Securities, RBC Capital Markets, Paradigm Capital Inc and
Versant Partners were underwriting the IPO.

The Winnipeg, Manitoba-based company said its common stock
has been conditionally approved for listing on Nasdaq under the
symbol “IMRS.”

IMRIS’ shares closed at C$6.00 on Friday on the Toronto
Stock Exchange.
(Reporting by Suzannah Benjamin in Bangalore; Editing by Anne
Pallivathuckal)

UPDATE 1-Canada’s IMRIS files for US IPO